BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12948412)

  • 1. [Detecting methylation of the calcitonin gene in monitoring treatment and disease evolution for myelogenous leukemia].
    Xie XH; Chen ZZ; Zhang XM; Huang MQ
    Ai Zheng; 2003 Jun; 22(6):616-9. PubMed ID: 12948412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of calcitonin gene methylation in chronic myeloid leukemia by using Hpa II-PCR].
    Tan B; Cao P; Qi Z
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(4):371-3. PubMed ID: 12080652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between blast crisis of chronic myeloid leukemias and abnormality of p16 and calcitonin genes].
    Xu D; Hong W; Wang S
    Zhonghua Zhong Liu Za Zhi; 2000 Mar; 22(2):151-3. PubMed ID: 11776646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].
    Liu XL; Zhou SY; Du QF; Zheng WY; Zhang S; Song LL; Xu B; Liu QF; Meng FY
    Ai Zheng; 2004 Apr; 23(4):421-5. PubMed ID: 15087031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypermethylation of the calcitonin gene as molecular genetic marker in detecting minimal residual disease of leukemia].
    Tang Y; Deng C; Du Q; Li G; Zeng Z; Zhang J; Miu S
    Zhonghua Nei Ke Za Zhi; 2001 Apr; 40(4):226-8. PubMed ID: 11798580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semi-quantitative study of calcitonin gene methylation in myelodysplastic syndrome.
    Wu S; Xie G; Bai R; Wang Y; Zhu P
    Chin Med J (Engl); 1998 Aug; 111(8):690-3. PubMed ID: 11245020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quantitative study of calcitonin gene methylation in myelodysplastic syndromes].
    Bai R; Wu S; Zhu P; Xue H; Xu Y; Qin X
    Zhonghua Xue Ye Xue Za Zhi; 1997 Jan; 18(1):17-20. PubMed ID: 15622744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypermethylation of the calcitonin gene and leukemia.
    Baruchel A; Sigaux F
    Nouv Rev Fr Hematol (1978); 1991; 33(6):551-3. PubMed ID: 1818314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of FLT3 gene and FLT3/ITD gene mutation in chronic myeloid leukemia and its significance].
    Xu B; Tian H; Zhou SY
    Ai Zheng; 2004 Oct; 23(10):1218-21. PubMed ID: 15473940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of dynamic detection of WT1 expression on monitoring minimal residual disease in leukemia patients following allogeneic bone marrow transplantation].
    Gu WY; Chen ZX; Hu SY; Zhu J; Wang ZL; Yan F; Wang W; Cen JN; Shen HL; Qian J
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):444-7. PubMed ID: 15854547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of HOXA genes by hypermethylation in myeloid and lymphoid malignancy is frequent and associated with poor prognosis.
    Strathdee G; Holyoake TL; Sim A; Parker A; Oscier DG; Melo JV; Meyer S; Eden T; Dickinson AM; Mountford JC; Jorgensen HG; Soutar R; Brown R
    Clin Cancer Res; 2007 Sep; 13(17):5048-55. PubMed ID: 17785556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Id4 gene methylation for detection of minimal residual disease in acute leukemia].
    Zhao Y; Yu L; Wang QS; Li HH; Bo J; Wang SH; Jin HJ; Lou FD
    Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):298-301. PubMed ID: 16875575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of cell heterogeneity and immunophenotypic changes on monitoring minimal residual disease in acute myeloid leukemia.
    Zelezníková T; Babusíková O
    Neoplasma; 2006; 53(6):500-6. PubMed ID: 17167719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRAME mRNA levels in cases with acute leukemia: clinical importance and future prospects.
    Paydas S; Tanriverdi K; Yavuz S; Disel U; Baslamisli F; Burgut R
    Am J Hematol; 2005 Aug; 79(4):257-61. PubMed ID: 16044453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and treatment of molecular relapse in acute myeloid leukemia with RUNX1 (AML1), CBFB, or MLL gene translocations: frequent quantitative monitoring of molecular markers in different compartments and correlation with WT1 gene expression.
    Doubek M; Palasek I; Pospisil Z; Borsky M; Klabusay M; Brychtova Y; Jurcek T; Jeziskova I; Krejci M; Dvorakova D; Mayer J
    Exp Hematol; 2009 Jun; 37(6):659-72. PubMed ID: 19463768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection and quantification of BCR-ABL transcripts in patients with chronic myeloid leukemia by real-time quantitative reverse transcriptase polymerase chain reaction].
    Xing W; Gu BW; Zhu YM; Jiang CL; Zhao RH; Wang AH; Sun HP; Li JM; Shen ZX; Chen Z; Chen SJ
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):453-7. PubMed ID: 15854550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypermethylation of the human calcitonin gene as a molecular marker in acute lymphoid leukemia].
    Marinich DV; Uss AL; Smirnova LA; Vorob'ev IA; Holmes J; Sulimova GE; Shevchuk TV; Bur'ianov IaI
    Vopr Med Khim; 2001; 47(5):537-46. PubMed ID: 11766265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on hypermethylation of the calcitonin gene in malignant hematological disorders].
    Tang Y; Deng C; Du Q; Li G
    Hua Xi Yi Ke Da Xue Xue Bao; 2001 Mar; 32(1):86-8. PubMed ID: 12733364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The methylation of CT gene in chronic myeloid leukemia].
    Zhou J; Xue Y; Lin B
    Zhonghua Nei Ke Za Zhi; 1997 Jun; 36(6):394-7. PubMed ID: 10374299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
    Liu QF; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY
    Ai Zheng; 2004 Apr; 23(4):426-9. PubMed ID: 15087032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.